Evidence map›Paper›PMID 31634241›Full record

ArticleChinese medical journal2019

Analysis of the lower incidence of medullary thyroid cancer in China.

Min Huang, Giuseppe Fanciulli, Shu-Qiong Wu, Zheng Zhang, Jing Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chinese medical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Efficacy and safety of selpercatinib in Chinese patients with advancedTherapeutic advances in medical oncology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Min HuangDepartment of Endocrinology, The Affiliated Xinhua Hospital of Hubei University of Chinese Medicine, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Wuhan, Hubei 430015, China.
Giuseppe FanciulliNeuroendocrine Unit, Department of Medical, Surgical and Experimental Medicine, University of Sassari, Sassari, Viale San Pietro, 07100 Sassari, Italy.
Shu-Qiong WuDepartment of Endocrinology, The Affiliated Xinhua Hospital of Hubei University of Chinese Medicine, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Wuhan, Hubei 430015, China.
Zheng ZhangDepartment of Endocrinology, The Affiliated Xinhua Hospital of Hubei University of Chinese Medicine, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Wuhan, Hubei 430015, China.
Jing ZhangDepartment of Endocrinology, The Affiliated Xinhua Hospital of Hubei University of Chinese Medicine, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Wuhan, Hubei 430015, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultCarcinoma, NeuroendocrineChinaFemaleHumansIncidenceMaleThyroid NeoplasmsYoung Adult

Identifiers

PMID31634241
PMCPMC6831069

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.